Solana ETF 获批前景:从「几乎无望」到「2025 年底前可期」,当前有哪些挑战?

Senzo

company

About

Senzo is a deep-tech bio-med company developing testing products and IP.

Details

Last Funding Type
Seed
Last Funding Money Raised
$1.90M
Industries
Biotechnology,Health Care,Health Diagnostics,Information Technology
Founded date
Jan 1, 2014
Number Of Employee
11 - 50
Operating Status
Active

Orphidia is developing a rapid blood diagnostic platform to simultaneously run common lab tests on a portable device.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
8
$3.90M
Senzo has raised a total of $3.90M in funding over 2 rounds. Their latest funding was raised on Dec 12, 2022 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 12, 2022 Seed $1.90M 2 BioAdvance
Wellness Coaches USA
Detail
Jul 21, 2022 Seed $2M 2 BioAdvance Detail
Jan 22, 2018 Seed 1 Detail
May 1, 2017 Seed 2 Detail
Feb 12, 2016 Convertable Note 2 Detail

Investors

Number of Lead Investors
Number of Investors
5
8
Senzo is funded by 8 investors. BioAdvance and Wellness Coaches USA are the most recent investors.
Investor Name Lead Investor Funding Round
BioAdvance Yes Seed
Wellness Coaches USA Yes Seed
Bossanova Investimentos Seed
Jay Zaveri Seed
Luigi Bajetti Seed
IndieBio Convertable Note
SOSV Convertable Note
Chris Sang Convertable Note

Employee Profiles

Number of Employee Profiles
2
Senzo has 2 current employee profiles, including Executive Aron Rachamim
Executive
Advisor